BrainStorm Cell receives notice from EPO to grant patent BrainStorm Cell Therapeutics announced that it has received notification from the European Patent Office of its intention to grant the company’s patent application No. EP06766101.7. This patent relates to the method of production of the company's proprietary stem cells induced to secrete large quantities of neurotrophic factors for the treatment of neurodegenerative diseases. The company's proprietary NurOwn stem cell therapy was developed from this differentiation method.
News For BCLI From The Last 14 Days
Check below for free stories on BCLI the last two weeks.